| Grantee's Name | Grantee's Address | Grant Date | Grant Amount | Grant Purpose | Amount Expended By Grantee | Any Diversion By Grantee? | Dates of Reports By Grantee | Date of Verification | Results of Verification |
|---|---|---|---|---|---|---|---|---|---|
|
HUNTERIAN MEDICINE LLC |
100 PACIFIC STREET UNIT 6 CAMBRIDGE,MA021394568 |
2019-09-09 | 350,000 | TO ASSIST IN THE FEASABILITY OF A CRISPR-MEDIATED APPROACH TO AUTOSOMAL DOMINANT RETINAL VASCULOPATHY WITH CEREBRAL LEUKODYSTROPHY (CAUSED BY THE HUMAN TREX-1 V235FS MUTATION) ("RVCL") AND/OR CREATING A CLINICAL PATH FOR AN RVCL THERAPEUTIC. | 350,000 | 1/31/2020, 2/28/2020, 3/31/2020, 4/30/2020, 5/31/2020, 6/30/2020, 7/31/2020, 8/31/2020 | THE FOUNDATION HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORTS PROVIDED FROM THE GRANTEE SO NO INDEPENDENT VERIFICATION OF THE REPORTS WERE REQUIRED OR MADE. |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| VANGUARD TOTAL STOCK MARKET ETF |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| INTL BUSINESS MACHINES CORP | 60,357 | 60,357 |
| GOLDMAN SACHS GROUP INC |
| Description | Amount |
|---|---|
| Prior Period Adjustment | 49,601 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| SPECIAL EVENTS FEES | 43,599 | |||
| BANK FEES | 1,666 | 1,666 | ||
| BROKERAGE FEES | 100 | 100 | ||
| Patient fees | 807 |
| Description | Revenue And Expenses Per Books | Net Investment Income | Adjusted Net Income |
|---|---|---|---|
| SPECIAL EVENT PROCEEDS | 374,792 |